Searchable abstracts of presentations at key conferences in endocrinology

ea0029oc4.6 | Pituitary Basic | ICEECE2012

Cell cycle G2/M transition is modulated by microRNAs in pituitary adenomas

Butz H. , Liko I. , Czirjak S. , Korbonits M. , Racz K. , Patocs A.

Background: Although pituitary adenomas are common endocrine neoplasms, the background of their pathogenesis has not clearly revealed. G1/S checkpoint alterations of the cell cycle have already been described in these tumours. MicroRNAs (miRs) which are small, non-coding RNA molecules, and posttranscriptionally regulate protein expression have also identified as potential pathogenic factors in certain cases. Our aim was to determine miR expression profile in pituitary adenomas...

ea0029p1102 | Neuroendocrinology | ICEECE2012

Differential diagnosis of acromegaly: a new gene for pachydermoperiostosis

Dalantaeva N. , Dzeranova L. , Atamanova T. , Diggle C. , Bonthron D. , Trivellin G. , Korbonits M.

Case report: 24-year. old man presented with change in facial appearance and joint pain. His symptoms began at puberty with the thickening and folding of the skin on the forehead and scalp and thickening of his fingers. These changes progressed over the next 5 years with marked seborrhoea, hyperhidrosis and linear palmar–plantar keratosis. The lower legs and forearms are cylindrically thickened, hands and feet increased in size, the terminal phalanges of the fingers show ...

ea0029p1334 | Pituitary Basic | ICEECE2012

Development of novel AIP (Aryl hydrocarbon receptor-interacting protein) gene study models using the fruitfly and the zebrafish

Aflorei E. , Chen C. , McGonnell I. , Fowkes R. , Grossman A. , Tapon N. , Stanewsky R. , Korbonits M.

Introduction: Mutations in AIP have been associated with the familial isolated pituitary adenoma (FIPA) syndrome, an autosomal dominant disease with incomplete penetrance characterised by pituitary adenomas in a familial setting. However, the mechanisms by which AIP inactivation promotes pituitary tumorigenesis are unknown. Studies of AIP in model organisms, such as the fruitfly, harbouring the AIP orthologue CG1847, as well as the zebrafish, are theoretically promising models...

ea0019oc22 | Cardiovascular metabolism | SFEBES2009

The effects of ghrelin and cannabinoids on AMP-activated protein kinase (AMPK) activity in growth hormone-secretagogue receptor (GHS-R) knockout mice

Lim CT , Kola B , Feltrin D , Perez-Tilve D , Grossman AB , Tschop MH , Korbonits M

Introduction: Ghrelin is a potent orexigenic brain-gut peptide with lipogenic and diabetogenic effects, possibly mediated by GHS-R. Cannabinoids also have orexigenic and lipogenic effects. AMPK is a regulator of energy homeostasis and we have previously shown that ghrelin and cannabinoids stimulate hypothalamic AMPK activity while inhibiting it in liver and adipose tissue, suggesting that AMPK mediates both the central appetite-inducing and peripheral effects of ghrelin and ca...

ea0012p121 | Steroids to include Cushing's | SFE2006

Role of glucocorticoids and AMPK in the regulation of lipogenesis and glycerogenesis in mesenteric adipose tissue

Lolli F , Christ-Crain M , Kola B , Wittman G , Fekete C , Grossman AB , Korbonits M

CushingÂ’s syndrome is characterized by a diverse set of clinical manifestations, including hypertension, apparent obesity and metabolic aberrations such as diabetes, dyslipidaemia, ultimately leading to the metabolic syndrome. AMP-activated protein kinase (AMPK) is an intracellular energy sensor. It integrates nutritional and hormonal signals by switching on catabolic pathways, such as fatty acid oxidation and glycolysis and switching off anabolic pathways, such as fatty ...

ea0011oc25 | Diabetes and metabolism | ECE2006

Cannabinoids increase AMP-activated protein kinase (AMPK) enzyme activity in the hypothalamus and heart via different signalling pathways – studies in CB1 knockout animals

Kola B , Christ-Crain M , Wittman G , Leontiou C , Grossman A , Fekete C , Korbonits M

We have recently reported that cannabinoids can stimulate hypothalamic and heart AMPK activity and can inhibit liver and adipose tissue AMPK activity in rats (Kola et al., JBC, 2005). These data are in accordance with the known orexigenic and adipogenic cannabinoid effects and also with their beneficial effects on the ischaemic heart. We have studied the effects of cannabinoids on AMPK activity in tissues from wild type (WT) and CB1 knockout (KO) mice to see if the CB1 ...

ea0011p383 | Diabetes, metabolism and cardiovascular | ECE2006

Direct effect of cannabinoids and ghrelin on liver and adipose cell metabolism via the AMP-activated protein kinase (AMPK) enzyme

Dalino P , Aguilar D , Isidori AM , Hubina E , Garcia EA , Kola B , Grossman AB , Korbonits M

Cannabinoids and ghrelin exert hypothalamic orexigenic effects and independent peripheral effects have also been reported. We have recently reported that ghrelin and cannabinoids can stimulate hypothalamic and heart AMPK activity, and can inhibit liver and adipose tissue AMPK activity, in rats (Kola et al., JBC, 2005). These data are concordant with the known orexigenic, adipogenic and diabetogenic effects of these compounds as well as with their beneficial effects on t...

ea0010oc6 | Reproduction, neuroendocrinology and diabetes | SFE2005

Ghrelin and cannabinoids increase food intake via stimulation of hypothalamic amp-activated protein kinase (AMPK)

Adams V , Kola B , Garcia E , Hubina E , Dalino P , Khalaf S , Grossman|M##Korbonits A

Cannabinoids and ghrelin are potent appetite stimulators. The ghrelin receptor (GHS-R1a), endocannabinoids and the cannabinoid 1 (CB1) receptor are expressed in the hypothalamus. There is evidence that the novel CB1 antagonist, rimonabant, causes weight loss by both central and peripheral effects. The AMP-activated protein kinase (AMPK) is a sensor of cellular energy status and regulates the energy metabolism within the single cell but also at whole body level. We have shown p...

ea0009p20 | Diabetes and metabolism | BES2005

Is ghrelin involved in BMI determination in patients with type 2 diabetes?

Garcia E , Gueorguiev M , Lecoeur C , Grossman A , Walley A , Froguel P , Korbonits M

Ghrelin is an orexigenic hormone, the endogenous ligand of the previously orphan growth-hormone-secretagogue receptor (GHS-R). Recently, it has been reported that pancreatic beta-cells are replaced by ghrelin-producing cells in a diabetic mice model implicating these genes as attractive candidates in the aetiology of type 2 diabetes (T2D) (PNAS;101:2924). The ghrelin gene is located at 3p25-26 and its cognate receptor at 3q26. We aimed to test for an association of these two g...

ea0009p89 | Endocrine tumours and neoplasia | BES2005

Cell cycle dysregulation in breast cancer - the roles of Jab1 and Archipelago

Bonner S , Morris D , Korbonits M , Laban C , McCarthy K , Al-Mufti R , Carpenter R , Grossman A

The cell cycle occupies a pivotal role in the control of cellular proliferation, a critical point being activation of CyclinE which is held in check by the inhibitor p27. CyclinE is targeted for degradation by the F-box protein Archipelago (Ago/Fbw7/cdc4), while p27 is exported out of the nucleus by Jun activation domain-binding protein 1 (Jab1). Over-expression of CyclinE has been reported in breast cancer. We have now explored the role of Jab1 and Ago in mediating changes in...